Total Funding
52
39
Total FundingPost-IPO Equity raised
Growth Score
-11 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
156986
Conduit Pharmaceuticals is a clinical-stage biopharmaceutical company providing solutions for the unmet medical needs of patients.
- Joanne Holland: Chief Scientific OfficerPast Role: Nuformix, CCTO and Co-founder
About the Company
Conduit Pharmaceuticals is a biopharmaceutical company that offers the development and commercialization of clinical assets. The company aims to meet the needs of patients and develop new treatments by focusing on clinical assets from pharmaceutical companies. They have considerable knowledge and understanding of the pharmaceutical market which
facilitates the selection of specific clinical assets.
